DCS操作工

山东京新药业有限公司

Chinese pharmaceutical manufacturer established in 2020 in the green chemical park of the Dajiawa subdistrict in the Binhai district of Weifang, Shandong, with one hundred and twenty million yuan of registered capital and wholly invested by the listed Zhejiang Jingxin Pharmaceutical. Builds and operates a full industry chain pharmaceutical health production base with total planned investment of about four billion yuan on a thousand mu site, covering production lines for active pharmaceutical ingredients, advanced intermediates and finished formulations. Its products include fluoroquinolone antibacterials and cardio-cerebrovascular and psychiatric and neurological active ingredients and intermediates.